These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16029449)

  • 1. Hypermethylation of the suppressor of cytokine signalling-1 (SOCS-1) in myelodysplastic syndrome.
    Brakensiek K; Länger F; Schlegelberger B; Kreipe H; Lehmann U
    Br J Haematol; 2005 Jul; 130(2):209-17. PubMed ID: 16029449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant methylation of the negative regulators RASSFIA, SHP-1 and SOCS-1 in myelodysplastic syndromes and acute myeloid leukaemia.
    Johan MF; Bowen DT; Frew ME; Goodeve AC; Reilly JT
    Br J Haematol; 2005 Apr; 129(1):60-5. PubMed ID: 15801956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line.
    To KF; Chan MW; Leung WK; Ng EK; Yu J; Bai AH; Lo AW; Chu SH; Tong JH; Lo KW; Sung JJ; Chan FK
    Br J Cancer; 2004 Oct; 91(7):1335-41. PubMed ID: 15354212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressor of cytokine signalling-1 gene silencing in acute myeloid leukaemia and human haematopoietic cell lines.
    Watanabe D; Ezoe S; Fujimoto M; Kimura A; Saito Y; Nagai H; Tachibana I; Matsumura I; Tanaka T; Kanegane H; Miyawaki T; Emi M; Kanakura Y; Kawase I; Naka T; Kishimoto T
    Br J Haematol; 2004 Sep; 126(5):726-35. PubMed ID: 15327527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic inactivation of SOCS-1 by CpG island hypermethylation in human gastric carcinoma.
    Oshimo Y; Kuraoka K; Nakayama H; Kitadai Y; Yoshida K; Chayama K; Yasui W
    Int J Cancer; 2004 Dec; 112(6):1003-9. PubMed ID: 15386345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma.
    Galm O; Yoshikawa H; Esteller M; Osieka R; Herman JG
    Blood; 2003 Apr; 101(7):2784-8. PubMed ID: 12456503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition.
    Weber A; Hengge UR; Bardenheuer W; Tischoff I; Sommerer F; Markwarth A; Dietz A; Wittekind C; Tannapfel A
    Oncogene; 2005 Oct; 24(44):6699-708. PubMed ID: 16007169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of the suppressor of cytokine signaling-3 promoter in human non-small-cell lung cancer.
    He B; You L; Xu Z; Mazieres J; Lee AY; Jablons DM
    Clin Lung Cancer; 2004 May; 5(6):366-70. PubMed ID: 15217536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling.
    van de Geijn GJ; Gits J; Touw IP
    J Leukoc Biol; 2004 Jul; 76(1):237-44. PubMed ID: 15107455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic relevance of aberrant SOCS-1 gene promoter methylation in myelodysplastic syndromes patients.
    Chaubey R; Sazawal S; Mahapatra M; Chhikara S; Saxena R
    Int J Lab Hematol; 2015 Apr; 37(2):265-71. PubMed ID: 25123164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional down-regulation of the Wnt antagonist SFRP1 in haematopoietic cells of patients with different risk types of MDS.
    Reins J; Mossner M; Neumann M; Platzbecker U; Schumann C; Thiel E; Hofmann WK
    Leuk Res; 2010 Dec; 34(12):1610-6. PubMed ID: 20471677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation status of suppressor of cytokine signaling-1 gene in hepatocellular carcinoma.
    Miyoshi H; Fujie H; Moriya K; Shintani Y; Tsutsumi T; Makuuchi M; Kimura S; Koike K
    J Gastroenterol; 2004 Jun; 39(6):563-9. PubMed ID: 15235874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AKAP12, a gene with tumour suppressor properties, is a target of promoter DNA methylation in childhood myeloid malignancies.
    Flotho C; Paulun A; Batz C; Niemeyer CM
    Br J Haematol; 2007 Sep; 138(5):644-50. PubMed ID: 17686059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of SOCS1 methylation in myelodysplastic syndrome.
    Wu SJ; Yao M; Chou WC; Tang JL; Chen CY; Ko BS; Huang SY; Tsay W; Chen YC; Shen MC; Wang CH; Yeh YC; Tien HF
    Br J Haematol; 2006 Nov; 135(3):317-23. PubMed ID: 16978223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms.
    Fukushima N; Sato N; Sahin F; Su GH; Hruban RH; Goggins M
    Br J Cancer; 2003 Jul; 89(2):338-43. PubMed ID: 12865927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma.
    Niwa Y; Kanda H; Shikauchi Y; Saiura A; Matsubara K; Kitagawa T; Yamamoto J; Kubo T; Yoshikawa H
    Oncogene; 2005 Sep; 24(42):6406-17. PubMed ID: 16007195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication of SOCS-1 gene methylation in acute myeloid leukaemia.
    Watanabe D; Naka T; Kishimoto T
    Br J Haematol; 2004 Dec; 127(5):608-9. PubMed ID: 15566367
    [No Abstract]   [Full Text] [Related]  

  • 18. Methylation-mediated silencing of SOCS-1 gene in hepatocellular carcinoma derived from cirrhosis.
    Okochi O; Hibi K; Sakai M; Inoue S; Takeda S; Kaneko T; Nakao A
    Clin Cancer Res; 2003 Nov; 9(14):5295-8. PubMed ID: 14614012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic dysregulation of the Jak/STAT pathway by frequent aberrant methylation of SHP1 but not SOCS1 in acute leukaemias.
    Chim CS; Wong AS; Kwong YL
    Ann Hematol; 2004 Aug; 83(8):527-32. PubMed ID: 14762685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
    Lejeune D; Demoulin JB; Renauld JC
    Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.